Regulatory Pressure & Supply Shock: Why Europe’s Drug Shortages Became Chronic – and What Everyone’s Missing
“Shortages aren’t accidents; they’re features of how the market is built.” Outside declared emergencies EMA…
Deep Dives
In-depth analysis and long-form articles.
Cracking Down on Orphan Drug Abuse: The ORPHAN Cures Act and Its Impact
Orphan Drug Profits vs. Patients: The Orphan Drug Act of 1983 was meant to encourage…
Gaming Generic Drug Approvals: Legitimate Loopholes and Illicit Tactics
Introduction: Generic drugs and their global counterparts are meant to break monopolies and drive down…
505(b)(2): The Fast Track to Innovation in Pharma
Connecting the Past and Future of Drug Development 505(b)(2): Towards the Future, While Reflecting the Past While…